Items tagged with Drug-susceptible TB

The Lancet: Results of Phase 2b trial of novel TB regimen PaMZ show potential to shorten, improve TB treatment (post with simple image)

Phase 3 STAND trial launched to advance PaMZ through final stage of testing.

Treating drug-sensitive TB in India: Implementation of daily therapy with fixed-dose combinations (post with simple image)

A briefing document outlines critical steps needed to implement a new policy from the Indian government to switch to standard daily TB treatment using fixed-dose combinations. This change, which is in line with global recommendations for proper treatment, is welcome but has yet to be put into action.

Tuberculosis in adults and children (post with simple image)

A monograph written for healthcare workers in any setting who are faced with the complex care for patients with tuberculosis.

New clinical practice guidelines: Treatment of drug-susceptible TB (post with simple image)

Jointly developed by the American Thoracic Society, U.S. Centers for Disease Control and Prevention and Infectious Diseases Society of America.

Are pretomanid-containing regimens for TB a victory or a victory narrative? (post with simple image)

"Given the evidence base available to us currently, can we claim pretomanid a victory? We think more research is needed before pretomanid can be celebrated as a promising treatment for people with tuberculosis."

Landmark TB trial identifies shorter-course treatment regimen (post with simple image)

Landmark phase III trial shows that the shorter regimen containing rifapentine and moxifloxacin can safely and effectively cure TB in four months.

SHINE trial on shorter treatment for children with minimal TB (post with simple image)

TB treatment can be shortened from six to four months in 80% of children.

Landmark TB trials results published in New England Journal of Medicine (post with simple image)

A shorter regimen containing rifapentine and moxifloxacin can cure TB in four months.

An Activist’s Guide to Shorter Treatment for Drug-Sensitive TB (post with simple image)

This new resource provides activists with information about two shorter treatment regimens for drug-sensitive TB, and equips them with actions they can take and arguments they can use to advocate for access to those regimens.

Page 3 of 3 · Total posts: 0

←First 2 3